Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Rowinski

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Swiss Medical Weekly|April 5, 2019
High-throughput sequencing in clinical oncology: from past to presentBenoîte Mery, Alexis Vallard, Elise Rowinski, et al.
Bulletin Du Cancer|June 19, 2024
[Adherence to endocrine therapy: A major issue in breast cancer management]Florence Coussy, Marie Robert, Cristian Villanueva, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Samuel Jones, Alexis Vallard, et al.
Anticancer Research|November 4, 2021
Cardio-Oncology Preclinical Models: A Comprehensive ReviewWafa Bouleftour, Benoite Mery, Elise Rowinski, et al.
American Journal of Clinical Oncology|July 18, 2019
Maintenance Therapy in Metastatic Solid Tumors: Innovative Strategy or Simple Second-line Treatment?Elise Rowinski, Pierre Fournel, Emilie Bernichon, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Chloé Rancoule, Elise Rowinski, et al.
Oncology|April 3, 2019
Advocacy for a New Oncology Research Paradigm: The Model of Bevacizumab in Triple-Negative Breast Cancer in a French Cohort StudyBenoîte Mery, Elise Rowinski, Alexis Vallard, et al.
Expert Opinion on Drug Safety|September 23, 2021
Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending storyCharlène Rivier, Benoite Mery, Elise Rowinski, et al.
Bulletin Du Cancer|December 29, 2019
[From bench to bedside for new treatment paradigms in chordomas: An update]Benoîte Méry, Elise Rowinski, Mathilde Guinand, et al.
American Journal of Clinical Oncology|March 23, 2022
Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 PatientsBenoite Mery, Elise Rowinski, Charlène Rivier, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Swiss Medical Weekly|April 5, 2019
High-throughput sequencing in clinical oncology: from past to presentBenoîte Mery, Alexis Vallard, Elise Rowinski, et al.
Bulletin Du Cancer|June 19, 2024
[Adherence to endocrine therapy: A major issue in breast cancer management]Florence Coussy, Marie Robert, Cristian Villanueva, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Samuel Jones, Alexis Vallard, et al.
Anticancer Research|November 4, 2021
Cardio-Oncology Preclinical Models: A Comprehensive ReviewWafa Bouleftour, Benoite Mery, Elise Rowinski, et al.
American Journal of Clinical Oncology|July 18, 2019
Maintenance Therapy in Metastatic Solid Tumors: Innovative Strategy or Simple Second-line Treatment?Elise Rowinski, Pierre Fournel, Emilie Bernichon, et al.
Bulletin Du Cancer|January 1, 2019
Benoîte Mery, Chloé Rancoule, Elise Rowinski, et al.
Oncology|April 3, 2019
Advocacy for a New Oncology Research Paradigm: The Model of Bevacizumab in Triple-Negative Breast Cancer in a French Cohort StudyBenoîte Mery, Elise Rowinski, Alexis Vallard, et al.
Expert Opinion on Drug Safety|September 23, 2021
Breast cancer treatment-related cardiovascular disturbances: advocacy for a watchful attitude in this never-ending storyCharlène Rivier, Benoite Mery, Elise Rowinski, et al.
Bulletin Du Cancer|December 29, 2019
[From bench to bedside for new treatment paradigms in chordomas: An update]Benoîte Méry, Elise Rowinski, Mathilde Guinand, et al.
American Journal of Clinical Oncology|March 23, 2022
Cardiovascular Diseases Following Breast Cancer: Towards a Case-by-Case Assessment Through a Prediction Risk Score Model in 943 PatientsBenoite Mery, Elise Rowinski, Charlène Rivier, et al.
Pageof 2